Researchers at the Leslie Dan Faculty of Pharmacy have devised an advanced drug delivery system for the treatment of ovarian cancer. PoLi, developed by Professors Micheline Piquette-Miller and Christine Allen, is an implantable film that destroys cancer cells while minimizing the side-effects of chemotherapy. The small implant, infused with cancer-killing drugs, is inserted directly into a tumour site after surgical removal of primary tumours. It steadily releases the drug over a two-month period, and dissolves naturally – it does not have to be surgically removed. “The PoLi implant has promise in the treatment of other cancers, including head and neck,” says Piquette-Miller. “We are also developing an injectable gel-based implant formulation that could be administered directly to the tumour site without surgery. This could also be used in the treatment of breast and prostate cancers.” PoLi still requires clinical trials, and a possible partnership with industry is being explored through Innovations at U of T.
Recent Posts
Meet Anne Dale, Dentistry’s Unofficial Historian
The museum she curates at the Faculty of Dentistry holds thousands of objects that tell the story of the profession in Canada
Heroes of Our Time
Members of the U of T community are working alongside colleagues from around the world to respond to the pandemic
Whose Stories Do We Tell?
The Dictionary of Canadian Biography aims to record noteworthy lives from “all points of view.” Six decades into its mission, what that means is still up for debate
